Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease.

Because Pugh has never shied away from showing a little (or a lot) of skin, she wore the centerpiece over nothing but the tiniest black triangle bra and matching high-waisted underwear.

The Black experience isn’t always well represented in Hollywood, but the best Black movies on Netflix right now are well-curated in Netflix’s Black Stories collection. However, like every ...

Sep. 17, 2024 — With the help of NASA's Hubble Space Telescope, an international team of scientists has found more black holes in the early universe than has previously been reported.

Because Pugh has never shied away from showing a little (or a lot) of skin, she wore the centerpiece over nothing but the tiniest black triangle bra and matching high-waisted underwear. With help from ...

Black Friday deals are near, and yes, you read that right. Amazon has just confirmed the dates for its second Prime Day sale, which will take place on October 8 and 9. This kicks off the 2024 ...

The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It targets high-risk HR-positive, HER2-negative stage II and III patients ...

The US Food and Drug Administration (FDA) has approved a label expansion for Novartis’s Kisqali (ribociclib), allowing it to be used as an add-on therapy in early breast cancer patients.

Kisqali has been FDA-approved with an aromatase inhibitor as postsurgical treatment for some with early breast cancer at a high risk of recurrence. The Food and Drug Administration (FDA) has approved ...

Novartis NVS announced positive data on breast cancer drug Kisqali (ribociclib) from the late-stage study, NATALEE. This late-breaking data from this four-year post-hoc analysis was presented at ...